Immunophenotypic measurable residual disease (MRD) in acute myeloid leukemia: Is multicentric MRD assessment feasible?

There is no fulltext present in this item.

Title:	Immunophenotypic measurable residual disease (MRD) in acute myeloid leukemia: Is multicentric MRD assessment feasible?
Author(s):	Brooimans, Rik A.; Velden, V.H. van der; Boeckx, N.; Slomp, J.; Preijers, F.W. ; Marvelde, Jeroen G. te; Kelder, A.; Schuurhuis, G.J.
Publication year:	2019
Source:	Leukemia Research, vol. 76, (2019), pp. 39-47
ISSN:	0145-2126
DOI:	https://doi.org/10.1016/j.leukres.2018.11.014
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/201053
Display more details
Subject:	All institutes and research themes of the Radboud University Medical Center Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences
Organization:	Laboratory Medicine
Journal title:	Leukemia Research
Volume:	vol. 76
Page start:	p. 39
Page end:	p. 47